Patents by Inventor Yuri Futerman

Yuri Futerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of halobetasol propionate
    Patent number: 7208485
    Abstract: The present invention provides a crystalline halobetasol propionate selected from the group consisting of halobetasol propionate having crystalline Form I characterized by power X-ray diffraction peak positions and intensities as set forth in Table 1 herein, halobetasol propionate having crystalline Form II characterized by power X-ray diffraction peak positions and intensities as set forth in Table 2 herein, halobetasol propionate having crystalline Form III characterized by power X-ray diffraction peak positions and intensities as set forth in Table 3 herein, halobetasol propionate having crystalline Form IV characterized by power X-ray diffraction peak positions and intensities as set forth in Table 4 herein, halobetasol propionate having crystalline Form V characterized by power X-ray diffraction peak positions and intensities as set forth in Table 5 herein, and halobetasol propionate having crystalline Form VI characterized by power X-ray diffraction peak positions and intensities as set forth in Table 6
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: April 24, 2007
    Assignee: Chemagis Ltd.
    Inventors: Itai Adin, Yuri Futerman, Ori Lerman, Alexander Weisman, Chaim Ashkenazi, Joseph Kaspi
  • Crystalline imatinib base and production process therefor
    Publication number: 20060223817
    Abstract: Provided is crystalline imatinib base form I and processes for producing crystalline imatinib base form I, which is suitable for preparing imatinib salts such as, e.g., the mesylate salt. Also provided is a process for producing a salt of imatinib from crystalline imatinib base form I.
    Type: Application
    Filed: May 15, 2006
    Publication date: October 5, 2006
    Applicant: CHEMAGIS LTD.
    Inventors: Itai Adin, Yuri Futerman, Carmen Iustain
  • Novel crystalline forms of 6alpha, 9alpha -difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene 17beta-carboxylic acid and processes for preparation thereof
    Publication number: 20060019937
    Abstract: Novel crystalline forms II, III, IV, V, VI, VII and VIII of 6?,9?-difluoro-11?-hydroxy-16?-methyl-3-oxo-17?-propionyloxyandrosta-1,4-diene-17?-carboxylic acid, a chemical intermediate useful in the preparation of fluticasone propionate, and novel methods of making these forms, substantially free of water, are disclosed.
    Type: Application
    Filed: July 26, 2005
    Publication date: January 26, 2006
    Inventors: Itai Adin, Carmen Iustain, Yuri Futerman
  • Crystalline forms of halobetasol propionate
    Publication number: 20040138191
    Abstract: The present invention provides a crystalline halobetasol propionate selected from the group consisting of halobetasol propionate having crystalline Form I characterized by power X-ray diffraction peak positions and intensities as set forth in Table 1 herein, halobetasol propionate having crystalline Form II characterized by power X-ray diffraction peak positions and intensities as set forth in Table 2 herein, halobetasol propionate having crystalline Form III characterized by power X-ray diffraction peak positions and intensities as set forth in Table 3 herein, halobetasol propionate having crystalline Form IV characterized by power X-ray diffraction peak positions and intensities as set forth in Table 4 herein, halobetasol propionate having crystalline Form V characterized by power X-ray diffraction peak positions and intensities as set forth in Table 5 herein, and halobetasol propionate having crystalline Form VI characterized by power X-ray diffraction peak positions and intensities as set forth in Table 6
    Type: Application
    Filed: January 13, 2003
    Publication date: July 15, 2004
    Applicant: CHEMAGIS LTD.
    Inventors: Itai Adin, Yuri Futerman, Ori Lerman, Alexander Weisman, Chaim Ashkenazi, Joseph Kaspi
  • Crystalline forms of halobetasol propionate
    Publication number: 20040138192
    Abstract: The present invention provides a crystalline halobetasol propionate selected from the group consisting of halobetasol propionate having crystalline Form I characterized by power X-ray diffraction peak positions and intensities as set forth in Table 1 herein, halobetasol propionate having crystalline Form II characterized by power X-ray diffraction peak positions and intensities as set forth in Table 2 herein, halobetasol propionate having crystalline Form III characterized by power X-ray diffraction peak positions and intensities as set forth in Table 3 herein, halobetasol propionate having crystalline Form IV characterized by power X-ray diffraction peak positions and intensities as set forth in Table 4 herein, halobetasol propionate having crystalline Form V characterized by power X-ray diffraction peak positions and intensities as set forth in Table 5 herein, and halobetasol propionate having crystalline Form VI characterized by power X-ray diffraction peak positions and intensities as set forth in Table 6
    Type: Application
    Filed: December 5, 2003
    Publication date: July 15, 2004
    Applicant: CHEMAGIS LTD.
    Inventors: Itai Adin, Yuri Futerman, Ori Lerman, Alexander Weisman, Chaim Ashkenazi, Joseph Kaspi